JB Capital
AZN icon

JB Capital’s AstraZeneca AZN Stock Holding History

JB Capital’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$18.8M Buy
116,375
+1,350
+1% +$225K 0.64% 32
2026
Q2 		$21.8M Buy
+115,025
New +$21.6M 0.76% 30
2022
Q3 		– Sell
-4,076
Closed -$539K – 164
2022
Q2 		$539K Buy
4,076
+71
+2% +$9.32K 0.06% 148
2022
Q1 		$532K Sell
4,005
-503
-11% -$60.3K 0.05% 156
2021
Q4 		$525K Buy
4,508
+38
+0.9% +$4.47K 0.05% 163
2021
Q3 		$537K Buy
+4,470
New +$520K 0.07% 168

Other funds holding AZN

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
ASR Vermogensbeheer
ASR Vermogensbeheer Utrecht, Netherlands $10.1B AUM 30.4% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
ZWJ Investment Counsel
ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return
Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Bank Pictet & Cie (Europe)
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.31B AUM 25.55% 1-Year Est. Return
Oslo Pensjonsforsikring
Oslo Pensjonsforsikring Oslo $863M AUM 18.29% 1-Year Est. Return

JB Capital's AZN Position: Q3 2026 in Review

JB Capital increased its AstraZeneca (AZN) stake by 1.2% in Q3 2026, buying an estimated $225K and bringing the position to 116,375 shares worth $18.8M. The position accounts for 0.64% of the portfolio, ranked #32.

JB Capital first reported a position in AZN in Q3 2021 and has held it in 6 quarters since. The position peaked at $21.8M in Q2 2026. 306 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • JB Capital held 116,375 shares of AstraZeneca worth $18.8M as of Q3 2026.
  • JB Capital bought 1,350 AstraZeneca shares in Q3 2026, an estimated $225K.
  • AstraZeneca made up 0.64% of JB Capital's portfolio in Q3 2026, its #32 holding.
  • JB Capital first reported a position in AstraZeneca in Q3 2021 and has held it in 6 quarters since.
  • JB Capital's AstraZeneca position peaked at $21.8M in Q2 2026.
  • 306 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on JB Capital's 13F filing for Q3 2026, filed 19 Oct 2026.